Cardiol Therapeutics (CRDL) Competitors $1.08 -0.01 (-0.46%) As of 03:40 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRDL vs. AUTL, DMAC, MBX, BNTC, IMRX, CTNM, GALT, DSGN, DRUG, and RCKTShould you be buying Cardiol Therapeutics stock or one of its competitors? The main competitors of Cardiol Therapeutics include Autolus Therapeutics (AUTL), DiaMedica Therapeutics (DMAC), MBX Biosciences (MBX), Benitec Biopharma (BNTC), Immuneering (IMRX), Contineum Therapeutics (CTNM), Galectin Therapeutics (GALT), Design Therapeutics (DSGN), Bright Minds Biosciences (DRUG), and Rocket Pharmaceuticals (RCKT). These companies are all part of the "pharmaceutical products" industry. Cardiol Therapeutics vs. Its Competitors Autolus Therapeutics DiaMedica Therapeutics MBX Biosciences Benitec Biopharma Immuneering Contineum Therapeutics Galectin Therapeutics Design Therapeutics Bright Minds Biosciences Rocket Pharmaceuticals Autolus Therapeutics (NASDAQ:AUTL) and Cardiol Therapeutics (NASDAQ:CRDL) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings. Does the media refer more to AUTL or CRDL? In the previous week, Cardiol Therapeutics had 8 more articles in the media than Autolus Therapeutics. MarketBeat recorded 13 mentions for Cardiol Therapeutics and 5 mentions for Autolus Therapeutics. Cardiol Therapeutics' average media sentiment score of 1.35 beat Autolus Therapeutics' score of 1.16 indicating that Cardiol Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Autolus Therapeutics 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cardiol Therapeutics 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, AUTL or CRDL? Autolus Therapeutics has a beta of 1.87, suggesting that its stock price is 87% more volatile than the S&P 500. Comparatively, Cardiol Therapeutics has a beta of 1.03, suggesting that its stock price is 3% more volatile than the S&P 500. Do institutionals & insiders hold more shares of AUTL or CRDL? 72.8% of Autolus Therapeutics shares are owned by institutional investors. Comparatively, 12.5% of Cardiol Therapeutics shares are owned by institutional investors. 25.7% of Autolus Therapeutics shares are owned by insiders. Comparatively, 5.3% of Cardiol Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has stronger valuation and earnings, AUTL or CRDL? Cardiol Therapeutics has lower revenue, but higher earnings than Autolus Therapeutics. Cardiol Therapeutics is trading at a lower price-to-earnings ratio than Autolus Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAutolus Therapeutics$29.93M13.20-$220.66M-$0.84-1.77Cardiol TherapeuticsN/AN/A-$26.77M-$0.34-3.19 Is AUTL or CRDL more profitable? Autolus Therapeutics' return on equity of -56.18% beat Cardiol Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Autolus TherapeuticsN/A -56.18% -29.61% Cardiol Therapeutics N/A -232.26%-158.19% Do analysts recommend AUTL or CRDL? Autolus Therapeutics currently has a consensus target price of $9.12, suggesting a potential upside of 514.14%. Cardiol Therapeutics has a consensus target price of $8.00, suggesting a potential upside of 637.33%. Given Cardiol Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Cardiol Therapeutics is more favorable than Autolus Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Autolus Therapeutics 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Cardiol Therapeutics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.50 SummaryAutolus Therapeutics beats Cardiol Therapeutics on 8 of the 15 factors compared between the two stocks. Get Cardiol Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRDL vs. The Competition Export to ExcelMetricCardiol TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$93.25M$2.51B$5.65B$10.30BDividend YieldN/A56.32%5.68%4.61%P/E Ratio-3.1923.2275.8526.09Price / SalesN/A574.52514.78169.46Price / CashN/A174.1537.5661.52Price / Book4.935.1612.886.30Net Income-$26.77M$32.95M$3.29B$271.03M7 Day Performance-2.25%0.15%-0.25%-0.14%1 Month Performance-4.82%5.11%3.88%6.44%1 Year Performance-48.82%1.29%68.42%28.85% Cardiol Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRDLCardiol Therapeutics2.8245 of 5 stars$1.09-0.5%$8.00+637.3%-50.5%$93.25MN/A-3.1920Positive NewsAnalyst RevisionAUTLAutolus Therapeutics4.007 of 5 stars$1.32-4.3%$9.12+590.9%-55.6%$367.28M$29.93M-1.57330Positive NewsAnalyst ForecastDMACDiaMedica Therapeutics2.1748 of 5 stars$7.01-1.1%$12.33+75.9%+70.0%$366.48MN/A-10.1620Positive NewsMBXMBX Biosciences2.8835 of 5 stars$10.87+0.4%$37.63+246.1%-12.6%$363.82MN/A-2.3936Trending NewsAnalyst ForecastGap DownBNTCBenitec Biopharma1.7206 of 5 stars$13.70-1.1%$26.00+89.8%+57.6%$363.57M$80K-9.0720Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionIMRXImmuneering3.5094 of 5 stars$7.86-7.4%$13.75+74.9%+216.1%$352.93M$320K-4.1660Trending NewsAnalyst ForecastGap UpCTNMContineum Therapeutics2.5113 of 5 stars$12.39+0.3%$22.75+83.6%-44.2%$346.46M$50M-5.6331News CoverageAnalyst ForecastGap UpGALTGalectin Therapeutics2.0045 of 5 stars$4.50-16.2%$6.00+33.3%+77.9%$344MN/A-7.039Positive NewsHigh Trading VolumeDSGNDesign Therapeutics0.3503 of 5 stars$5.86-2.8%N/A+19.0%$343.40MN/A-5.2340Positive NewsDRUGBright Minds Biosciences3.268 of 5 stars$48.66-0.2%$81.00+66.5%+4,148.3%$343.39MN/A-52.32N/APositive NewsRCKTRocket Pharmaceuticals4.8017 of 5 stars$3.22+1.9%$16.73+419.7%-81.8%$340.98MN/A-1.28240Positive NewsGap Down Related Companies and Tools Related Companies AUTL Alternatives DMAC Alternatives MBX Alternatives BNTC Alternatives IMRX Alternatives CTNM Alternatives GALT Alternatives DSGN Alternatives DRUG Alternatives RCKT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CRDL) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRDL Stock Alerts